LegitScript Certified
Licensed clinicians
Compounded in the USAFree discreet shippingFSA and HSA eligibleNo insurance requiredSome patients ask about lower-dose GLP-1 protocols. Here is what microdosing means, who asks about it, and why only a clinician can decide.
Microdosing generally refers to using a lower dose of a GLP-1 medication than a standard titration schedule would call for. It is not a formal clinical category and there is no single agreed definition. Any dose used in your care is set by your clinician.
The most common reasons are tolerability, maintaining progress after reaching a goal, and cost. Those are all reasonable things to raise during your assessment or a check-in message.
Published research on GLP-1 medications studies specific approved dosing schedules. Lower-dose protocols have not been evaluated the same way, so no outcome should be assumed. Placeholder pending client clinical and legal review.
A clinician licensed in your state reviews your history, goals, tolerability, and any side effects you report, then chooses a dose if treatment is appropriate. You cannot select your own dose, and dose changes always go through your clinician.
Message your care team if a dose feels too strong, if side effects are interfering with daily life, or if your goals change. Never adjust your dose on your own.
Your clinician can only make a dosing decision once they have your full history. The assessment is free and takes about five minutes.
Individual results vary. Weight care outcomes depend on medical history, dose, nutrition, and activity. No result is guaranteed.
Cuora Health is not a compounding manufacturer. The brand name medications Zepbound™ and Mounjaro® are manufactured by Eli Lilly and Company™. The brand name medications Wegovy® and Ozempic® are manufactured by Novo Nordisk A/S. Cuora Health does NOT manufacture or distribute these medications and has no direct affiliation with Eli Lilly and Company™ or Novo Nordisk A/S. The products offered through Cuora Health are compounded medications prepared by licensed compounding pharmacies. These formulations are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone clinical trials to evaluate their safety, efficacy, or therapeutic equivalence to any FDA-approved medication. They are not intended to diagnose, treat, cure, or prevent any disease and are not substitutes for FDA-approved medications such as MOUNJARO®, ZEPBOUND™, Wegovy®, or Ozempic®. Any statements regarding effectiveness or safety relate only to the general mechanisms of the active ingredients (for example, semaglutide or tirzepatide) and do not pertain to Cuora Health's specific compounded formulations. These products are not approved for cosmetic weight loss and should only be used under the supervision of a licensed healthcare provider. Product images are for illustration only. This copy is a placeholder pending client legal review.
